WA
Consensus Narrative from 13 Analysts
Expanding Electronic Materials And Biopharma Will Broaden Overseas Markets
Key Takeaways Ajinomoto is prioritizing expansion in electronic materials, CDMO biopharma, and organic growth overseas to enhance revenue and profitability. Strategic shifts in coffee products and operational efficiency improvements aim to stabilize revenue, improve margins, and boost earnings per share.
View narrativeJP¥7.03k
FV
10.1% undervalued intrinsic discount6.07%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
15 days ago author updated this narrative